glp 1 agonists for alcohol use disorder IUPHAR review – Glucagon-like peptide-1 (GLP-1) and substance disorders: An emerging pharmacotherapeutic target GLP-1 receptor agonists are promising
Description
Astrup, A
Vidal, J., Flores, L., Jimnez, A., Pan, A
Nevertheless, numerous ongoing trials are investigating the cardiometabolic effects of GLP-1RAs in patients with mental illness, especially for those on antipsychotics (Supplementary Section 3)such research should therefore address the abovementioned knowledge gap
Front Oncol
A few studies suggested that stopping GLP-1s is associated with regaining at least a portion of the lost weight, but its possible that if you go slowly, you may be more likely to keep the weight off
